L.A. City Councilmember Curren Price charged with embezzlement and perjury

L.A. City Councilmember Curren Price was charged with embezzlement, perjury and conflict of interest on Tuesday, according to the Los Angeles County district attorney’s office.

News from California, the nation and world – Los Angeles Times

Inflation hits the Costco food court: Chicken bake price up $1, soft drinks up 10 cents

Costco raised the price of its chicken bake to $ 3.99 and its 20-ounce soft drink to $ 0.59. The $ 1.99 pizza slice and $ 1.50 hot dog combo remain untouched.

California

Average US gasoline price jumps 39 cents to $5.10 per gallon

The average price at the pump is $ 1.97 higher than it was one year ago.
ABC News: Top Stories

Amgen sets one lower list price for its cholesterol drug

Drugmaker Amgen Inc said on Thursday that starting next year, its official list price for cholesterol drug Repatha will be the lower price it began offering last year to patients on Medicare and those paying for the drug out-of-pocket.


Reuters: Health News

Gene therapy gets FDA approval — and a $2 million price tag

The US Food and Drug Administration approved a treatment Friday for a genetic disease called spinal muscular atrophy that causes infants’ muscles to waste away, potentially killing them before age 2.


CNN.com – RSS Channel – Health

Diabetes Health in The News Podcast: Eli Lilly Announces a Generic Insulin at Half the Price of Their Most Popular Brand

If you have been struggling with insulin prices, compromising your over health because you cannot afford your medication, Today Eli Lilly is offering you some relief, a new generic insulin on the market at half the price of their most popular brand.

The lower-priced version will be called Insulin Lispro—the same molecule as Humalog—and will be available in vial and pen options. The list price of a single vial will be $ 137.35. The list price of a five-pack of KwikPens will be $ 265.20. Vials and pens of the lower-priced insulin have been manufactured, and Lilly will now work with supply chain partners to make them available in pharmacies as quickly as possible. It will be made available as an authorized generic through a Lilly subsidiary, ImClone Systems. Humalog will also remain available for people who want to continue accessing it through their current insurance plans. Introducing an alternative insulin option allows Lilly to provide a lower-priced insulin more quickly while providing payers time to renegotiate downstream contracts and adjust to new system economics.

If you have Medicare D, this will help with your coverage gap.

If you have any question, call the Lilly Diabetes Solution Center at (833) 808-1234 to learn whether Lilly’s Insulin Lispro, or another option, is the best financial choice for you.


Page Array – Diabetes Health

US won’t declare opioid emergency, Price says

Health and Human Services Secretary Tom Price announced Tuesday that President Donald Trump has no immediate plans to declare the nation’s opioid epidemic a public health emergency, a decision that flies in the face of the key recommendation by the President’s bipartisan opioid commission.


CNN.com – RSS Channel – Health

How drug price pressure helped sink Novo’s insulin pill

LONDON (Reuters) – Commercial rather than technical hurdles ultimately torpedoed Novo Nordisk’s bid to make an oral form of insulin, its chief executive said on Wednesday, underscoring the impact of U.S. price pressure on the world’s top insulin supplier.


Reuters: Health News

Exclusive: EpiPen price hikes add millions to Pentagon costs

NEW YORK/WASHINGTON (Reuters) – Mylan NV’s price hikes on EpiPens have added millions to U.S. Department of Defense spending since 2008 as the agency covered more prescriptions for the lifesaving allergy shot at near retail prices, government data provided to Reuters shows.


Reuters: Health News

GSK cuts vaccine price for refugees, bowing to pressure

LONDON (Reuters) – GlaxoSmithKline is cutting the price charged for its pneumococcal vaccine when given to refugees, following complaints about the product’s “exorbitant” cost by medical charity Medecins Sans Frontieres.


Reuters: Health News